Freitag Gregory Gene
SEC insider (Form 3/4/5 filer). CIK 0001492710. Director at PDS Biotechnology Corp (PDSB) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 12, 2026. Located in PRINCETON, NJ.
Companies Freitag Gregory Gene has filed insider reports for
- PDS Biotechnology Corp (PDSB): Director
- ZyVersa Therapeutics, Inc. (ZVSA): Director
Freitag Gregory Gene
CIK: 0001492710
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 12, 2026PDSB
PDS Biotechnology Corp
AwardDirectEmployee Stock Option (Right to Buy)
54.9K shares- - Jul 11, 2025ZVSA
ZyVersa Therapeutics, Inc.
AwardDirectStock Options
11.1K shares- - Jun 11, 2025PDSB
PDS Biotechnology Corp
AwardDirectEmployee Stock Option (Right to Buy)
22.7K shares- - Feb 28, 2025PDSB
PDS Biotechnology Corp
PurchaseDirect15.1K shares at avg. $1.66$25K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 12, 2026 |  PDSB PDS Biotechnology Corp | Award Employee Stock Option (Right to Buy) | 54,876 | - | - | Direct |
| Jul 11, 2025 |  ZVSA ZyVersa Therapeutics, Inc. | Award Stock Options | 11,066 | - | - | Direct |
| Jun 11, 2025 | PDSB PDS Biotechnology Corp | Award Employee Stock Option (Right to Buy) | 22,700 | - | - | Direct |
| Feb 28, 2025 | PDSB PDS Biotechnology Corp | Purchase | 15,060 | $1.66 | $25,000 | Direct |
1-4 of 4 transactions